GENEVA, Oct. 30 -- SYSTIMMUNE, INC. filed a patent application (US2026/025030) for “TRIPTOLIDE-BASED DRUG CONJUGATES AND METHODS OF MAKING AND USING THEREOF”. With publication no. WO/2026/226872, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07J 73/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....